- 50 views
It is a sigh of relief for HIV patients globally after the technological innovation of a new class of anti-HIV medicines with long-acting effects allowing people at risk of HIV infection and those living with the virus to take medicine twice a year. This was disclosed by National Syndemic Disease Control Council CEO Ruth Masha during the 55th Programme Coordinating Board for the United Nations on HIV/AIDS (UNAIDS) who said the medicine will be injectable.
Connect with KBC Online; Subscribe to our channel: https://t.ly/86BKN Follow us on Twitter: https://twitter.om/KBCChannel1 Find us on Facebook: https://www.facebook.com/kbcchannel1TV Check our website: https://www.kbc.co.ke/
#kbcchannel1 #news #kbclive
An injectable HIV medicine in the offing
- 6 Jan 2025 - Western leaders back Natembeya after Ichungwa's harsh outburst
- 6 Jan 2025 - Senators hit out at governors for mismanaging health facilities
- 6 Jan 2025 - Ruto allies hit out at Gachagua, campaign for 2027 elections
- 6 Jan 2025 - Kala-azar: Body-wasting disease, leaves tragedy in its wake
- 6 Jan 2025 - Grieving mothers and families demand justice as abductions surge
- 6 Jan 2025 - CBC crisis: Books, funds and classrooms cloud Grade Nine shift
- 6 Jan 2025 - Growing disquiet in Western region as Uhuru, Raila allies join Cabinet
- 6 Jan 2025 - End of an era: No more Form One admissions as reforms start
- 6 Jan 2025 - Area suffers marginalisation and systemic neglect marked by bloody protests, poverty and unfulfilled promises.
- 6 Jan 2025 - Kindiki said he merely took a break for the festive season having not rested since his appointment in 2022.